Skip to main content

Lipid Mediators and Skin Diseases

  • Chapter
Bioactive Lipid Mediators
  • 1306 Accesses

Abstract

Lipid mediators, such as prostanoids and leukotrienes, are metabolites of arachidonic acid released in various pathophysiological conditions that exert a range of actions mediated through their respective receptors expressed on target cells. Although it has been difficult to analyze the physiological role of prostanoids or leukotrienes, recent developments in the disruption of both the respective genes and receptor-selective compounds have enabled us to investigate the physiological roles for lipid mediators. It has been demonstrated that each receptor of lipid mediators has multiple functions in a context-dependent manner, which sometimes results in opposite—excitatory and inhibitory—outcomes. The balance of the production and the receptor expression of each lipid mediator has been proved to be important for maintaining the homeostasis of our body. Here, we review new findings on the functions of prostanoids and leukotrienes in skin inflammatory diseases, focusing on contact dermatitis, atopic dermatitis, and psoriasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pasparakis M, Haase I, Nestle FO (2014) Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol 14(5):289–301. doi:10.1038/nri3646

    Article  CAS  PubMed  Google Scholar 

  2. Heath WR, Carbone FR (2013) The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 14(10):978–985. doi:10.1038/ni.2680

    Article  CAS  PubMed  Google Scholar 

  3. Honda T, Tokura Y, Miyachi Y, Kabashima K (2010) Prostanoid receptors as possible targets for anti-allergic drugs: recent advances in prostanoids on allergy and immunology. Curr Drug Targets 11(12):1605–1613

    Article  CAS  PubMed  Google Scholar 

  4. Hirata T, Narumiya S (2012) Prostanoids as regulators of innate and adaptive immunity. Adv Immunol 116:143–174. doi:10.1016/B978-0-12-394300-2.00005-3

    Article  CAS  PubMed  Google Scholar 

  5. Yokomizo T (2011) Leukotriene B4 receptors: novel roles in immunological regulations. Adv Enzyme Regul 51(1):59–64. doi:10.1016/j.advenzreg.2010.08.002

    Article  CAS  PubMed  Google Scholar 

  6. Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79(4):1193–1226

    CAS  PubMed  Google Scholar 

  7. Honda T, Egawa G, Grabbe S, Kabashima K (2013) Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis. J Invest Dermatol 133(2):303–315. doi:10.1038/jid.2012.284

    Article  CAS  PubMed  Google Scholar 

  8. Peiser M, Tralau T, Heidler J, Api AM, Arts JH, Basketter DA, English J, Diepgen TL, Fuhlbrigge RC, Gaspari AA, Johansen JD, Karlberg AT, Kimber I, Lepoittevin JP, Liebsch M, Maibach HI, Martin SF, Merk HF, Platzek T, Rustemeyer T, Schnuch A, Vandebriel RJ, White IR, Luch A (2012) Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci 69(5):763–781. doi:10.1007/s00018-011-0846-8

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Kabashima K, Sakata D, Nagamachi M, Miyachi Y, Inaba K, Narumiya S (2003) Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat Med 9(6):744–749. doi:10.1038/nm872

    Article  CAS  PubMed  Google Scholar 

  10. Shiraishi N, Nomura T, Tanizaki H, Nakajima S, Narumiya S, Miyachi Y, Tokura Y, Kabashima K (2013) Prostaglandin E2-EP3 axis in fine-tuning excessive skin inflammation by restricting dendritic cell functions. PLoS One 8(7):e69599. doi:10.1371/journal.pone.0069599

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Del Prete A, Shao WH, Mitola S, Santoro G, Sozzani S, Haribabu B (2007) Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood 109(2):626–631. doi:10.1182/blood-2006-02-003665

  12. Angeli V, Staumont D, Charbonnier AS, Hammad H, Gosset P, Pichavant M, Lambrecht BN, Capron M, Dombrowicz D, Trottein F (2004) Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. J Immunol 172(6):3822–3829

    Article  CAS  PubMed  Google Scholar 

  13. Angeli V, Faveeuw C, Roye O, Fontaine J, Teissier E, Capron A, Wolowczuk I, Capron M, Trottein F (2001) Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 193(10):1135–1147

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Yamamoto Y, Otani S, Hirai H, Nagata K, Aritake K, Urade Y, Narumiya S, Yokozeki H, Nakamura M, Satoh T (2011) Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2. Am J Pathol 179(1):302–314. doi:10.1016/j.ajpath.2011.03.047

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ (2000) The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103(5):757–768

    Article  CAS  PubMed  Google Scholar 

  16. Nagamachi M, Sakata D, Kabashima K, Furuyashiki T, Murata T, Segi-Nishida E, Soontrapa K, Matsuoka T, Miyachi Y, Narumiya S (2007) Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1. J Exp Med 204(12):2865–2874. doi:10.1084/jem.20070773

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, Kuroiwa K, Sugimoto Y, Narumiya S (2009) Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 15(6):633–640. doi:10.1038/nm.1968

    Article  CAS  PubMed  Google Scholar 

  18. Nakajima S, Honda T, Sakata D, Egawa G, Tanizaki H, Otsuka A, Moniaga CS, Watanabe T, Miyachi Y, Narumiya S, Kabashima K (2010) Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity. J Immunol 184(10):5595–5603. doi:10.4049/jimmunol.0903260

    Article  CAS  PubMed  Google Scholar 

  19. Kabashima K, Murata T, Tanaka H, Matsuoka T, Sakata D, Yoshida N, Katagiri K, Kinashi T, Tanaka T, Miyasaka M, Nagai H, Ushikubi F, Narumiya S (2003) Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol 4(7):694–701. doi:10.1038/ni943

    Article  CAS  PubMed  Google Scholar 

  20. Kanda N, Mitsui H, Watanabe S (2004) Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. J Allergy Clin Immunol 114(6):1403–1409. doi:10.1016/j.jaci.2004.08.041

    Article  CAS  PubMed  Google Scholar 

  21. Takeshita K, Yamasaki T, Nagao K, Sugimoto H, Shichijo M, Gantner F, Bacon KB (2004) CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Int Immunol 16(7):947–959. doi:10.1093/intimm/dxh096

    Article  CAS  PubMed  Google Scholar 

  22. Boehme SA, Chen EP, Franz-Bacon K, Sasik R, Sprague LJ, Ly TW, Hardiman G, Bacon KB (2009) Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms. Int Immunol 21(1):1–17. doi:dxn118

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Honda T, Matsuoka T, Ueta M, Kabashima K, Miyachi Y, Narumiya S (2009) Prostaglandin E2-EP3 signaling suppresses skin inflammation in murine contact hypersensitivity. J Allergy Clin Immunol 124(4):809–818 e802. doi:10.1016/j.jaci.2009.04.029

  24. Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH (2003) Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol 4(10):965–973. doi:10.1038/ni972

    Article  CAS  PubMed  Google Scholar 

  25. Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, Luster AD (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4(10):982–990. doi:10.1038/ni970

    Article  CAS  PubMed  Google Scholar 

  26. Kanda N, Watanabe S (2007) Leukotriene B4 enhances tumour necrosis factor-alpha-induced CCL27 production in human keratinocytes. Clin Exp Allergy 37(7):1074–1082. doi:10.1111/j.1365-2222.2007.02743.x

    Article  CAS  PubMed  Google Scholar 

  27. Fogh K, Herlin T, Kragballe K (1989) Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. J Allergy Clin Immunol 83(2 pt 1):450–455

    Article  CAS  PubMed  Google Scholar 

  28. Laouini D, Elkhal A, Yalcindag A, Kawamoto S, Oettgen H, Geha RS (2005) COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization. J Allergy Clin Immunol 116(2):390–396. doi:10.1016/j.jaci.2005.03.042

    Article  CAS  PubMed  Google Scholar 

  29. Fedyk ER, Phipps RP (1996) Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci U S A 93(20):10978–10983

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. He R, Oyoshi MK, Wang JY, Hodge MR, Jin H, Geha RS (2010) The prostaglandin D2 receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge. J Allergy Clin Immunol 126(4):784–790. doi:10.1016/j.jaci.2010.07.006

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Matsushima Y, Satoh T, Yamamoto Y, Nakamura M, Yokozeki H (2011) Distinct roles of prostaglandin D2 receptors in chronic skin inflammation. Mol Immunol 49(1-2):304–310. doi:10.1016/j.molimm.2011.08.023

    Article  CAS  PubMed  Google Scholar 

  32. Sarashina H, Tsubosaka Y, Omori K, Aritake K, Nakagawa T, Hori M, Hirai H, Nakamura M, Narumiya S, Urade Y, Ozaki H, Murata T (2014) Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation. J Immunol 192(1):459–465. doi:10.4049/jimmunol.1302080

    Article  CAS  PubMed  Google Scholar 

  33. Satoh T, Moroi R, Aritake K, Urade Y, Kanai Y, Sumi K, Yokozeki H, Hirai H, Nagata K, Hara T, Utsuyama M, Hirokawa K, Sugamura K, Nishioka K, Nakamura M (2006) Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 177(4):2621–2629

    Article  CAS  PubMed  Google Scholar 

  34. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193(2):255–261

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Yoshimura-Uchiyama C, Iikura M, Yamaguchi M, Nagase H, Ishii A, Matsushima K, Yamamoto K, Shichijo M, Bacon KB, Hirai K (2004) Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Clin Exp Allergy 34(8):1283–1290. doi:10.1111/j.1365-2222.2004.02027.x

    Article  CAS  PubMed  Google Scholar 

  36. Iwasaki M, Nagata K, Takano S, Takahashi K, Ishii N, Ikezawa Z (2002) Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Invest Dermatol 119(3):609–616. doi:10.1046/j.1523-1747.2002.01862.x

    Article  CAS  PubMed  Google Scholar 

  37. Oyoshi MK, He R, Li Y, Mondal S, Yoon J, Afshar R, Chen M, Lee DM, Luo HR, Luster AD, Cho JS, Miller LS, Larson A, Murphy GF, Geha RS (2012) Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation. Immunity 37(4):747–758. doi:10.1016/j.immuni.2012.06.018

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Neisius U, Olsson R, Rukwied R, Lischetzki G, Schmelz M (2002) Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol 47(1):28–32

    Article  PubMed  Google Scholar 

  39. Arai I, Takano N, Hashimoto Y, Futaki N, Sugimoto M, Takahashi N, Inoue T, Nakaike S (2004) Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 505(1-3):229–235. doi:10.1016/j.ejphar.2004.10.031

    Article  CAS  PubMed  Google Scholar 

  40. Andoh T, Haza S, Saito A, Kuraishi Y (2011) Involvement of leukotriene B4 in spontaneous itch-related behaviour in NC mice with atopic dermatitis-like skin lesions. Exp Dermatol 20(11):894–898. doi:10.1111/j.1600-0625.2011.01346.x

    Article  CAS  PubMed  Google Scholar 

  41. Andoh T, Nishikawa Y, Yamaguchi-Miyamoto T, Nojima H, Narumiya S, Kuraishi Y (2007) Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. J Invest Dermatol 127(8):2042–2047. doi:10.1038/sj.jid.5700810

    Article  CAS  PubMed  Google Scholar 

  42. Wagner EF, Schonthaler HB, Guinea-Viniegra J, Tschachler E (2010) Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol 6(12):704–714. doi:10.1038/nrrheum.2010.157

    Article  CAS  PubMed  Google Scholar 

  43. Ikai K (1999) Psoriasis and the arachidonic acid cascade. J Dermatol Sci 21(3):135–146

    Article  CAS  PubMed  Google Scholar 

  44. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP, Lubberts E (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 182(9):5836–5845. doi:10.4049/jimmunol.0802999

    Article  PubMed  Google Scholar 

  45. Sumida H, Yanagida K, Kita Y, Abe J, Matsushima K, Nakamura M, Ishii S, Sato S, Shimizu T (2014) Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis. J Immunol 192(9):4361–4369. doi:10.4049/jimmunol.1302959

    Article  CAS  PubMed  Google Scholar 

  46. Schirmer C, Klein C, von Bergen M, Simon JC, Saalbach A (2010) Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells. Blood 116(10):1715–1725. doi:10.1182/blood-2010-01-263509

    Article  CAS  PubMed  Google Scholar 

  47. Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D (2004) Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J 18(11):1318–1320. doi:10.1096/fj.03-1367fje

    CAS  PubMed  Google Scholar 

  48. Ofuji S, Furukawa F, Miyachi Y, Ohno S (1984) Papuloerythroderma. Dermatologica 169(3):125–130

    Article  CAS  PubMed  Google Scholar 

  49. Nakahigashi K, Doi H, Otsuka A, Hirabayashi T, Murakami M, Urade Y, Zouboulis CC, Tanizaki H, Egawa G, Miyachi Y, Kabashima K (2012) PGD2 induces eotaxin-3 via PPAR-gamma from sebocytes: a possible pathogenesis of eosinophilic pustular folliculitis. J Allergy Clin Immunol 129(2):536–543. doi:10.1016/j.jaci.2011.11.034

    Article  CAS  PubMed  Google Scholar 

  50. Sugita K, Ikenouchi-Sugita A, Nakayama Y, Yoshioka H, Nomura T, Sakabe J, Nakahigashi K, Kuroda E, Uematsu S, Nakamura J, Akira S, Nakamura M, Narumiya S, Miyachi Y, Tokura Y, Kabashima K (2013) Prostaglandin E2 is critical for the development of niacin-deficiency-induced photosensitivity via ROS production. Sci Rep 3:2973. doi:10.1038/srep02973

    Article  PubMed Central  PubMed  Google Scholar 

  51. Kabashima K, Nagamachi M, Honda T, Nishigori C, Miyachi Y, Tokura Y, Narumiya S (2007) Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors. Lab Invest J Tech Methods Pathol 87(1):49–55. doi:10.1038/labinvest.3700491

    Article  CAS  Google Scholar 

  52. Williams TJ, Morley J (1973) Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246(5430):215–217

    Article  CAS  PubMed  Google Scholar 

  53. Morimoto K, Shirata N, Taketomi Y, Tsuchiya S, Segi-Nishida E, Inazumi T, Kabashima K, Tanaka S, Murakami M, Narumiya S, Sugimoto Y (2014) Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. J Immunol 192(3):1130–1137. doi:10.4049/jimmunol.1300290

    Article  CAS  PubMed  Google Scholar 

  54. Goulet JL, Pace AJ, Key ML, Byrum RS, Nguyen M, Tilley SL, Morham SG, Langenbach R, Stock JL, McNeish JD, Smithies O, Coffman TM, Koller BH (2004) E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J Immunol 173(2):1321–1326

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenji Kabashima .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Japan

About this chapter

Cite this chapter

Honda, T., Kabashima, K. (2015). Lipid Mediators and Skin Diseases. In: Yokomizo, T., Murakami, M. (eds) Bioactive Lipid Mediators. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55669-5_21

Download citation

Publish with us

Policies and ethics